MedTrace Logo

Citalopram and Self Emotional Processing

NCT04169230 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2019-11-19

No results posted yet for this study

Summary

This study is investigating the effect of an acute dose of citalopram on emotional processing about the self. Using a parallel-group double-blind design, participants will be randomised to receive either an acute dose of citalopram or placebo. Participants will then complete a number of widely used computer-based cognitive tasks measuring emotional processing biases towards the self.

This study has also been registered on OSF: https://osf.io/nhjvs/?view\_only=b39c49bddfd543b99b627dc992e49b45

Conditions

  • Molecular Mechanisms of Pharmacological Action
  • Depression
  • Depressive Disorder
  • Mental Disorder
  • Antidepressive Agents
  • Cognition

Interventions

DRUG

Citalopram

Single dose administration of citalopram (20mg)

DRUG

Placebo oral tablet

Single dose administration lactose placebo tablet

Sponsors & Collaborators

  • University of Bath

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Catherine Harmer, DPhil · University of Oxford

  • Katherine S Button, PhD · University of Bath

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04169230 on ClinicalTrials.gov